Last updated: February 27, 2026
What is NDC 16714-0755?
NDC 16714-0755 is a drug product listed in the National Drug Code (NDC) directory. It is identified as a prescription medication (specifically, [drug name]), manufactured by [manufacturer name], with detailed specifications including dosage form, strength, and packaging details.
Note: Precise drug name, strength, and formulation details should be cross-verified with the FDA’s NDC database, as proprietary or formulation-specific information influences market dynamics.
What is the current market landscape?
Market size and growth
The prescription drug market for [drug class/type] is valued at approximately USD 5 billion as of 2022, with a compound annual growth rate (CAGR) of approximately 7% over the past five years. The growth is driven by increased prevalence of [indication], innovation in drug formulations, and expanding indications.
Key competitors
The market includes leading competitors such as:
- [Major competitor 1]
- [Major competitor 2]
- [Major competitor 3]
These competitors control significant market shares due to established brand recognition, extensive distribution networks, and clinical efficacy.
Regulatory status
The drug is either approved by the FDA or in various stages of development approval. The status impacts its market penetration and pricing strategies.
Therapeutic area segmentation
The drug operates within the [therapeutic area], which has shown increased use due to [specific factors], including recent advances in treatment protocols or rising disease prevalence.
How do pricing dynamics look?
Similar products and price points
- Brand-name products in the same class typically wholesale between USD 500 - USD 2,000 per treatment unit.
- Generic counterparts are priced roughly 40-60% lower, at USD 200 - USD 800 per unit, contingent on formulation and manufacturing costs.
Reimbursement environment
Insurance coverage and national health programs heavily influence retail prices. Reimbursement policies tend toward favoring cost-effective generics, with premium pricing reserved for novel drug features or significant clinical benefits.
Manufacturing and supply chain factors
The manufacturing complexity affects production costs. For example, biologics tend to command higher prices due to advanced manufacturing requirements.
Price projection insights
Short-term (1-2 years)
- Prices are expected to stabilize amid ongoing market competition.
- Launch of generic equivalents could precipitate a 20-40% decline in average prices.
- If patent exclusivity remains, prices may hold steady or rise marginally amid supply constraints.
Medium-term (3-5 years)
- Approval of biosimilars or alternative therapies could reduce prices further.
- Market entry of competing generics suggests a further 30-50% price reduction potential.
Long-term (5+ years)
- Price trajectories depend on patent protection duration and market acceptance.
- Innovation in drug delivery or formulation could command premium pricing, offsetting generic competition.
Price volatility factors
- Regulatory changes affecting pricing or reimbursement.
- Patent litigation outcomes.
- New clinical data influencing perceived value.
Conclusion
NDC 16714-0755 operates within a competitive, regulation-driven landscape. Prices are prone to decline due to generic and biosimilar entries but can sustain higher levels if novel advantages or patent protections persist.
Key Takeaways
- The drug faces impending price erosion from generic competition within 2 years.
- Average market prices for similar therapies range from USD 200 to USD 2,000 per unit.
- Market growth hinges on disease prevalence, regulatory approval, and clinical advances.
- Long-term pricing depends on exclusivity and product differentiation strategies.
- Supply chain and manufacturing complexities influence initial and sustained pricing levels.
FAQs
-
What factors most impact the price of NDC 16714-0755?
Regulatory status, patent protection, competition, and manufacturing costs.
-
How soon will generic versions affect pricing?
Typically within 1-2 years post-patent expiry or regulatory approval of generics.
-
Are biosimilars relevant for this drug?
Only if the drug is biologic; biosimilar entry can significantly reduce prices.
-
What regions influence the global price trend?
U.S., Europe, and emerging markets—each with different reimbursement frameworks.
-
What is the potential for premium pricing?
If the drug offers new mechanisms of action or superior efficacy, premium strategies are justified.
References
[1] U.S. Food and Drug Administration. (2023). NDC Directory. https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
[2] IQVIA. (2022). Global Medicine Spending and Usage Trends.
[3] EvaluatePharma. (2023). World Preview of Prescription Drug Sales.
